Superworth

Cypherpunk Technologies EPS CYPH

Diluted earnings per share by quarter and over the last twelve months, from 2017.

Last 12 months, to Jun 30, 2026
−$0.08
Latest quarter, Q2 FY26
$0.18
Fiscal year 2025
−$0.57

Cypherpunk Technologies' earnings per share was −$0.08 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was $0.18.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.57n/a
FY2024−$1.84n/a
FY2023−$5.12n/a
FY2022−$4.80n/a
FY2021−$4.80n/a
FY2020−$8.50n/a
FY2019−$15.00n/a
FY2018−$18.00n/a
FY2017−$34.70n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26$0.18n/a−$0.08
Q1 FY26−$0.46n/a−$0.66
Q4 FY25$0.28n/a−$0.57
Q3 FY25−$0.08n/a−$1.22
Q2 FY25−$0.40n/a−$1.58
Q1 FY25−$0.37n/a−$1.70
Q4 FY24−$0.37n/a−$1.84
Q3 FY24−$0.44n/a−$1.93
Q2 FY24−$0.52n/a−$2.00
Q1 FY24−$0.51n/a−$2.39
Q4 FY23−$0.46n/a−$5.12
Q3 FY23−$0.51n/a−$5.73

Against its peers

Companies in Drug Manufacturers - General nearest Cypherpunk Technologies' size, closest first, today.

CompanyEPS, 12 monthsGrowth
CYPHCypherpunk Technologies−$0.08
NATRNatures Sunshine Products$1.01+36% a year
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
COLLCollegium Pharmaceutical$1.24+19% a year
ABUSArbutus Biopharma$0.78
AMPHAmphastar Pharmaceuticals$1.70−36% a year
OMEROmeros$1.52
Peer median$0.97

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Cypherpunk Technologies

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.